Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-031252

Chief Medical Officer acquired 33,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Huertas Pedro · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-05-16 Grant or award : show line 1 in the form +33,000 137,725 D
Loading xslF345X03/doc4.xml…